1. GSTP1Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications
   Filippo Martignano et al, 2016, Disease Markers CrossRef
2. piR-31470 epigenetically suppresses the expression of glutathione S-transferase pi 1 in prostate cancer via DNA methylation
   Ling Zhang et al, 2020, Cellular Signalling CrossRef
3. Progression inference for somatic mutations in cancer
   Leif E. Peterson et al, 2017, Heliyon CrossRef
4. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer
   Bing Yang et al, 2016, Cancer Biomarkers CrossRef
5. Recent Progress in Triple Negative Breast Cancer Research
   Fatima Zahra Mouh et al, 2016, Asian Pacific Journal of Cancer Prevention CrossRef
6. Promoter methylation of MCAM, ERα and ERβ in serum of early stage prostate cancer patients
   Mariana Brait et al, 2017, Oncotarget CrossRef
7. Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis
   Alexey A. Dmitriev et al, 2015, Disease Markers CrossRef
8. YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression
   Tianyu Shen et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef
9. Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine
   M. J. Alvarez-Cubero et al, 2017, Molecular Diagnosis & Therapy CrossRef
10. Association of glutathione-S-transferase p1 gene promoter methylation and the incidence of prostate cancer: a systematic review and meta-analysis
    Xueliang Zhou et al, 2019, Journal of Cancer Research and Clinical Oncology CrossRef
11. Demethylation of tumor necrosis factor-α converting enzyme promoter associated with high hepatitis B e antigen level in chronic hepatitis B
    Zhen-Li Wang, 2015, World Journal of Gastroenterology CrossRef
12. Promoter methylation of TRIM9 as a marker for detection of circulating tumor DNA in breast cancer patients
    Chieko Mishima et al, 2015, SpringerPlus CrossRef
13. DNMT1 is associated with cell cycle and DNA replication gene sets in diffuse large B-cell lymphoma
    Suet Kee Loo et al, 2018, Pathology - Research and Practice CrossRef
14. Epigenetics and prostate cancer: defining the timing of DNA methyltransferase deregulation during prostate cancer progression
    Vasiliki Tzelepi et al, 2020, Pathology CrossRef
15. The Interplay Between Prostate Cancer Genomics, Metabolism, and the Epigenome: Perspectives and Future Prospects
    Reema Singh et al, 2021, Frontiers in Oncology CrossRef
16. Dysregulation of DNA epigenetic modulators during prostate carcinogenesis in an eastern Indian patient population: Prognostic implications
    Anwesha Banerjee et al, 2024, Pathology - Research and Practice CrossRef
17. Decoding the Influence of Obesity on Prostate Cancer and Its Transgenerational Impact
    Mariana Santos-Pereira et al, 2023, Nutrients CrossRef
18. Epigenetic (De)regulation in Prostate Cancer
    Chenxi Xu et al, 2023, Epigenetics in Oncology CrossRef
19. One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling
    Joshua Corbin et al, 2016, International Journal of Molecular Sciences CrossRef
20. Evaluation of glutathione S‐transferase pi 1 expression and gene promoter methylation in Moroccan patients with urothelial bladder cancer
    Khaoula Hadami et al, 2018, Molecular Genetics & Genomic Medicine CrossRef
21. DNA methylation and histone modifications as epigenetic regulation in prostate cancer
    Maria Nowacka-Zawisza et al, 2017, Oncology Reports CrossRef
22. Demethylation of tumor necrosis factor-α converting enzyme predicts poor prognosis in acute-on-chronic hepatitis B liver failure
    Zhen-Li Wang et al, 2016, Clinics and Research in Hepatology and Gastroenterology CrossRef
23. Glutathione S‐transferase Pi 1 is a valuable predictor for cancer drug resistance in esophageal squamous cell carcinoma
    Shinpei Ogino et al, 2019, Cancer Science CrossRef
24. Tamoxifen therapy benefit predictive signature combining with prognostic signature in surgical‐only ER‐positive breast cancer
    Feng Lv et al, 2019, Journal of Cellular Physiology CrossRef